Analyst Ratings for Chemed (CHE)
CHE Rating Summary
CHE Price Target Summary
- Highest: $580.00 (Oppenheimer)
- Lowest: $436.00 (RBC Capital)
- Average: $485.25
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$485.25 (+11.2%)
* Over Last 12-Mos
Rating Score: 1.7 / 10
Percentile Rank: 12%
Rating Score: 1.7 / 10
Percentile Rank: 12%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/27/2026 | RBC Capital » Updated 4/27/2026 |
Ben Hendrix | Downgrade | Sector Perform (Outperform) |
436.00 (422.00) |
466.60 (436.27) |
-6.5% | Details |
| 2/26/2026 | BofA Securities | Joanna Gajuk | Downgrade | Neutral (Buy) |
450.00 (595.00) |
466.60 (436.27) |
-6.5% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
